Why RYBREVANT®
- 1st treatment for EGFR+ NSCLC with exon 19 deletions or exon 21 L858R substitution mutations
- 2nd treatment for EGFR+ NSCLC with exon 19 deletions or exon 21 L858R substitution mutations
- 1st treatment for EGFR+ NSCLC with exon 20 insertion mutations
- 2nd treatment for EGFR+ NSCLC with exon 20 insertion mutations
What to Expect
- 1st treatment for EGFR+ NSCLC with exon 19 deletions or exon 21 L858R substitution mutations
- 2nd treatment for EGFR+ NSCLC with exon 19 deletions or exon 21 L858R substitution mutations
- 1st treatment for EGFR+ NSCLC with exon 20 insertion mutations
- 2nd treatment for EGFR+ NSCLC with exon 20 insertion mutations
Savings & Support
